当前位置: 首页 > 详情页

Prophylactic Atropine Administration Prevents Vasovagal Response Induced by Cryoballoon Ablation in Patients with Atrial Fibrillation

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Natl Clin Res Ctr Cardiovasc Dis, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China; [2]CapitalMed Univ, Dept Cardiol, Beijing Anzhen Hosp, Beijing 100029, Peoples R China
出处:
ISSN:

关键词: vasovagal response atropine cryoballoon atrial fibrillation

摘要:
BackgroundCryoballoon (CB) ablation of pulmonary vein ostia often induces a vagal response. This prospective study was designed to assess the effectiveness of prophylactic intravenous administration of atropine on hemodynamic impairment induced by CB ablation in patients with atrial fibrillation. MethodsTwenty-five patients with paroxysmal atrial fibrillation undergoing CB ablation were prospectively enrolled and assigned to one of two groups. First 12 patients (trial group) were administered 1 mg of atropine before deflation of the CB, while the following 13 patients (control group) were given atropine only after the onset of the hemodynamic variation (decrease in heart rate and/or blood pressure). Treatment was considered effective when the hemodynamic variations were restored. ResultsIn the trial group, three patients with transient hypotension did not require supportive care throughout the procedures, and one patient with hypotension required supportive care. In the control group, hypotension, bradycardia, and mixed bradycardia with hypotension requiring supportive care occurred in six, three, and three patients, respectively. Overall, the rate of marked vagal responses was significantly lower when prophylactic atropine was administrated (4/12 patients vs 12/13 patients, respectively; P < 0.01). ConclusionsAtropine is significantly effective in the prevention of all types of vasovagal responses induced by CB ablation in patients with atrial fibrillation.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 心脏和心血管系统 4 区 工程:生物医学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 心脏和心血管系统 4 区 工程:生物医学
JCR分区:
出版当年[2015]版:
Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Q3 ENGINEERING, BIOMEDICAL
最新[2023]版:
Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Q3 ENGINEERING, BIOMEDICAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Capital Med Univ, Natl Clin Res Ctr Cardiovasc Dis, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, Natl Clin Res Ctr Cardiovasc Dis, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China; [2]CapitalMed Univ, Dept Cardiol, Beijing Anzhen Hosp, Beijing 100029, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16399 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院